
Sabiha Naim Qazi
Examiner (ID: 9181)
| Most Active Art Unit | 1616 |
| Art Unit(s) | 1612, 1627, 1629, 1611, 1616, 1628, 1621, 1202 |
| Total Applications | 2032 |
| Issued Applications | 930 |
| Pending Applications | 195 |
| Abandoned Applications | 909 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11082180
[patent_doc_number] => 20160279145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-29
[patent_title] => 'NOVEL CYTOTOXIC AGENTS THAT PREFERENTIALLY TARGET LEUKEMIA INHIBITORY FACTOR (LIF) FOR THE TREATMENT OF MALIGNANCIES AND AS NEW CONTRACEPTIVE AGENTS'
[patent_app_type] => utility
[patent_app_number] => 15/077099
[patent_app_country] => US
[patent_app_date] => 2016-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 20580
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15077099
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/077099 | Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for the treatment of malignancies and as new contraceptive agents | Mar 21, 2016 | Issued |
Array
(
[id] => 12259303
[patent_doc_number] => 20180078500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-22
[patent_title] => 'FIXED DOSE COMBINATION OF BRIMONIDINE AND TIMOLOL'
[patent_app_type] => utility
[patent_app_number] => 15/558515
[patent_app_country] => US
[patent_app_date] => 2016-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4557
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15558515
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/558515 | FIXED DOSE COMBINATION OF BRIMONIDINE AND TIMOLOL | Mar 16, 2016 | Abandoned |
Array
(
[id] => 11962000
[patent_doc_number] => 20170266154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'METHOD FOR TREATING ALZHEIMER\'S DISEASE AND 2, 3-BIPHOSPHOGLYCERATE METABOLISM DISORDER INDUCED'
[patent_app_type] => utility
[patent_app_number] => 15/071179
[patent_app_country] => US
[patent_app_date] => 2016-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 3086
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15071179
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/071179 | METHOD FOR TREATING ALZHEIMER'S DISEASE AND 2, 3-BIPHOSPHOGLYCERATE METABOLISM DISORDER INDUCED | Mar 14, 2016 | Abandoned |
Array
(
[id] => 11589678
[patent_doc_number] => 20170114089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'OXYSTEROLS AND HEDGEHOG SIGNALING'
[patent_app_type] => utility
[patent_app_number] => 15/055402
[patent_app_country] => US
[patent_app_date] => 2016-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 42899
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15055402
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/055402 | Oxysterols and hedgehog signaling | Feb 25, 2016 | Issued |
Array
(
[id] => 12231246
[patent_doc_number] => 20180064109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'Insect Repellent'
[patent_app_type] => utility
[patent_app_number] => 15/551782
[patent_app_country] => US
[patent_app_date] => 2016-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4026
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15551782
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/551782 | Insect Repellent | Feb 22, 2016 | Abandoned |
Array
(
[id] => 14003183
[patent_doc_number] => 10220019
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-05
[patent_title] => Method for treating pulmonary fibrosis comprising application of dimethylamino micheliolide
[patent_app_type] => utility
[patent_app_number] => 15/748624
[patent_app_country] => US
[patent_app_date] => 2016-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 2936
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15748624
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/748624 | Method for treating pulmonary fibrosis comprising application of dimethylamino micheliolide | Jan 27, 2016 | Issued |
Array
(
[id] => 16571768
[patent_doc_number] => 10893675
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-19
[patent_title] => Powder formulation containing insect repellent
[patent_app_type] => utility
[patent_app_number] => 15/548020
[patent_app_country] => US
[patent_app_date] => 2016-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 8651
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15548020
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/548020 | Powder formulation containing insect repellent | Jan 7, 2016 | Issued |
Array
(
[id] => 11023630
[patent_doc_number] => 20160220585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'NOVEL CRYSTAL FORM OF AN ORGANIC COMPOUND AND PROCESS FOR THE PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/980302
[patent_app_country] => US
[patent_app_date] => 2015-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3782
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14980302
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/980302 | NOVEL CRYSTAL FORM OF AN ORGANIC COMPOUND AND PROCESS FOR THE PREPARATION THEREOF | Dec 27, 2015 | Abandoned |
Array
(
[id] => 13424873
[patent_doc_number] => 20180263979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => COMBINATION OF RAF INHIBITORS AND AURORA KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/539183
[patent_app_country] => US
[patent_app_date] => 2015-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16869
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539183
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/539183 | COMBINATION OF RAF INHIBITORS AND AURORA KINASE INHIBITORS | Dec 21, 2015 | Abandoned |
Array
(
[id] => 12116498
[patent_doc_number] => 20180000084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'USE OF PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 15/540569
[patent_app_country] => US
[patent_app_date] => 2015-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22831
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15540569
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/540569 | USE OF PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY | Dec 20, 2015 | Abandoned |
Array
(
[id] => 14227145
[patent_doc_number] => 20190125745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => TREATMENT AND DIAGNOSIS OF CANCER
[patent_app_type] => utility
[patent_app_number] => 15/536921
[patent_app_country] => US
[patent_app_date] => 2015-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36852
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15536921
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/536921 | TREATMENT AND DIAGNOSIS OF CANCER | Dec 16, 2015 | Abandoned |
Array
(
[id] => 11962010
[patent_doc_number] => 20170266164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'NEW METHODS AND USES'
[patent_app_type] => utility
[patent_app_number] => 15/326849
[patent_app_country] => US
[patent_app_date] => 2015-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12181
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15326849
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/326849 | NEW METHODS AND USES | Dec 10, 2015 | Abandoned |
Array
(
[id] => 10811333
[patent_doc_number] => 20160157493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'COMPOSITION AND METHOD FOR SELECTIVE HERBICIDE'
[patent_app_type] => utility
[patent_app_number] => 14/965802
[patent_app_country] => US
[patent_app_date] => 2015-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6981
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14965802
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/965802 | COMPOSITION AND METHOD FOR SELECTIVE HERBICIDE | Dec 9, 2015 | Abandoned |
Array
(
[id] => 13563741
[patent_doc_number] => 20180333418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-22
[patent_title] => USE OF PAN FGFR INHIBITORS AND METHOD OF IDENTIFYING PATIENTS WITH CANCER ELIGIBLE FOR TREATMENT WITH A PAN FGFR INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 15/534033
[patent_app_country] => US
[patent_app_date] => 2015-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8987
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15534033
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/534033 | USE OF PAN FGFR INHIBITORS AND METHOD OF IDENTIFYING PATIENTS WITH CANCER ELIGIBLE FOR TREATMENT WITH A PAN FGFR INHIBITOR | Dec 7, 2015 | Abandoned |
Array
(
[id] => 10812070
[patent_doc_number] => 20160158231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'PYRIMIDINE HYDROXY AMIDE COMPOUNDS FOR TREATING PERIPHERAL NEUROPATHY'
[patent_app_type] => utility
[patent_app_number] => 14/959317
[patent_app_country] => US
[patent_app_date] => 2015-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8951
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14959317
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/959317 | PYRIMIDINE HYDROXY AMIDE COMPOUNDS FOR TREATING PERIPHERAL NEUROPATHY | Dec 3, 2015 | Abandoned |
Array
(
[id] => 10742690
[patent_doc_number] => 20160088841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-31
[patent_title] => 'SYNERGISTIC SEED TREATMENT COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/953720
[patent_app_country] => US
[patent_app_date] => 2015-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1925
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14953720
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/953720 | SYNERGISTIC SEED TREATMENT COMPOSITIONS | Nov 29, 2015 | Abandoned |
Array
(
[id] => 13687381
[patent_doc_number] => 20170354645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => METHODS FOR TREATING KIDNEY DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/524332
[patent_app_country] => US
[patent_app_date] => 2015-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15524332
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/524332 | METHODS FOR TREATING KIDNEY DISORDERS | Nov 23, 2015 | Abandoned |
Array
(
[id] => 11224461
[patent_doc_number] => 09452169
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-27
[patent_title] => 'Substituted diketopiperazines and their use as oxytocin antagonists'
[patent_app_type] => utility
[patent_app_number] => 14/946920
[patent_app_country] => US
[patent_app_date] => 2015-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4561
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14946920
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/946920 | Substituted diketopiperazines and their use as oxytocin antagonists | Nov 19, 2015 | Issued |
Array
(
[id] => 13689443
[patent_doc_number] => 20170355676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => USE OF TETRAHYDROPYRIDINES IN THE TREATMENT OF SODIUM CHANNEL RELATED DISEASE AND DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/522510
[patent_app_country] => US
[patent_app_date] => 2015-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8110
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15522510
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/522510 | Use of tetrahydropyridines in the treatment of sodium channel related disease and disorders | Nov 18, 2015 | Issued |
Array
(
[id] => 10729507
[patent_doc_number] => 20160075656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-17
[patent_title] => 'QUINOLINE AMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 14/945005
[patent_app_country] => US
[patent_app_date] => 2015-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32169
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14945005
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/945005 | QUINOLINE AMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS | Nov 17, 2015 | Abandoned |